ES468938A1 - Metodo de preparacion de auranofin. - Google Patents

Metodo de preparacion de auranofin.

Info

Publication number
ES468938A1
ES468938A1 ES468938A ES468938A ES468938A1 ES 468938 A1 ES468938 A1 ES 468938A1 ES 468938 A ES468938 A ES 468938A ES 468938 A ES468938 A ES 468938A ES 468938 A1 ES468938 A1 ES 468938A1
Authority
ES
Spain
Prior art keywords
auranofin
antiarthritic
preparing
preparing auranofin
potassiumsulfide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES468938A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
Original Assignee
SmithKline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Corp filed Critical SmithKline Corp
Publication of ES468938A1 publication Critical patent/ES468938A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Cosmetics (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Glass Compositions (AREA)
  • Steroid Compounds (AREA)
ES468938A 1977-04-21 1978-04-19 Metodo de preparacion de auranofin. Expired ES468938A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/789,603 US4131732A (en) 1977-04-21 1977-04-21 Method for preparing auranofin

Publications (1)

Publication Number Publication Date
ES468938A1 true ES468938A1 (es) 1978-12-16

Family

ID=25148131

Family Applications (1)

Application Number Title Priority Date Filing Date
ES468938A Expired ES468938A1 (es) 1977-04-21 1978-04-19 Metodo de preparacion de auranofin.

Country Status (20)

Country Link
US (1) US4131732A (es)
AR (1) AR215695A1 (es)
AT (1) AT361507B (es)
BG (1) BG28716A3 (es)
CH (1) CH633561A5 (es)
CS (1) CS194843B2 (es)
DD (1) DD136745A5 (es)
DK (1) DK150858C (es)
ES (1) ES468938A1 (es)
FI (1) FI64165C (es)
FR (1) FR2387996A1 (es)
IE (1) IE47046B1 (es)
IL (1) IL54528A0 (es)
IT (1) IT1094084B (es)
NO (1) NO146328C (es)
PL (1) PL111162B1 (es)
PT (1) PT67904B (es)
SE (1) SE444568B (es)
SU (1) SU795486A3 (es)
YU (1) YU39417B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4301152A (en) * 1979-10-26 1981-11-17 Merck & Co., Inc. Immunologic adjuvant
NZ228367A (en) * 1988-03-23 1992-02-25 Smithkline Beecham Corp Topical composition containing a gold compound for treating inflammatory conditions
US5527779A (en) * 1988-03-23 1996-06-18 Top Gold Pty Limited Topically applied gold organic complex
CN1057092C (zh) * 1997-10-31 2000-10-04 昆明贵金属研究所 金诺芬的制备方法
CA2814694C (en) * 2010-10-12 2019-01-29 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of treating giardiasis
WO2016124936A1 (en) 2015-02-06 2016-08-11 Auspherix Limited Inhibition of microbial persister cells
JP2018504434A (ja) 2015-02-06 2018-02-15 オースフェリクス・リミテッドAuspherix Limited オーラノフィンを使用してバイオフィルムを抑制及び分散する方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK135897B (da) * 1969-10-28 1977-07-11 Smith Kline French Lab Fremgangsmåde til fremstilling af trialkylphosphinguldhalogenider.
BE757672A (fr) * 1969-10-28 1971-04-19 Smith Kline French Lab Complexes d'auro-trialcoylphosphine de 1-beta-D-glucopyranosides
DK129847B (da) * 1969-10-28 1974-11-25 Smith Kline French Lab Analogifremgangsmåde til fremstilling af trialkylphosphinguldkomplekser af 1-β-D-glucopyranosider.

Also Published As

Publication number Publication date
IT1094084B (it) 1985-07-26
DD136745A5 (de) 1979-07-25
PT67904B (en) 1979-10-15
IE47046B1 (en) 1983-12-14
YU39417B (en) 1984-12-31
NO146328B (no) 1982-06-01
DK150858B (da) 1987-07-06
FI64165C (fi) 1983-10-10
US4131732A (en) 1978-12-26
CS194843B2 (en) 1979-12-31
SE444568B (sv) 1986-04-21
FR2387996A1 (fr) 1978-11-17
PL111162B1 (en) 1980-08-30
AR215695A1 (es) 1979-10-31
ATA274678A (de) 1980-08-15
SU795486A3 (ru) 1981-01-07
AT361507B (de) 1981-03-10
IL54528A0 (en) 1978-07-31
FI781155A (fi) 1978-10-22
DK150858C (da) 1987-12-07
IT7822402A0 (it) 1978-04-17
FR2387996B1 (es) 1980-08-01
YU95478A (en) 1982-10-31
FI64165B (fi) 1983-06-30
DK163978A (da) 1978-10-22
BG28716A3 (en) 1980-06-16
SE7804208L (sv) 1978-10-22
PT67904A (en) 1978-05-01
CH633561A5 (de) 1982-12-15
IE780753L (en) 1978-10-21
PL206281A1 (pl) 1979-03-12
NO146328C (no) 1982-09-08
NO781391L (no) 1978-10-24

Similar Documents

Publication Publication Date Title
MY102473A (en) Purine derivates and their pharmaceutical use
GR78987B (es)
IT1156745B (it) Farmaci contenenti composti sterolici 15-ossigenati e procedimento per impedire la biosintesi di acido mevalonico
ES482153A1 (es) Un procedimiento para preparar nuevas fenetanolaminas.
ES468938A1 (es) Metodo de preparacion de auranofin.
JPS5369821A (en) Production of cephazoline sodium for nonnoral dose
ES8607916A1 (es) Un procedimiento para la preparacion de medicamentos influenciadores de la circulacion sanguinea, que contienen compuestos de bis (carboxamida)
DE2963990D1 (en) Analgesic tablet and process for its preparation
ES472847A1 (es) Procedimiento para la preparacion de la 2-bromoergosina y sus sales acidas de adicion
GB1171156A (en) Improvements in or relating to Cycloalkane Derivatives and the Manufacture thereof
GB1207975A (en) Hydroxyalkylene bis(acylamino-2,4,6-triiodobenzoic acid) derivatives for use as x-ray visualization agents
NZ233704A (en) Dehydrocholecalciferol derivatives, pharmaceutical compositions thereof
FR2367737A1 (fr) Polypeptide, son procede de preparation et medicament le contenant
MY102991A (en) Medicaments for treating hypertension.
HUT54113A (en) Process for producing butenecarboxylic acid derivatives and pharmaceutical compositions comprising such compounds
FR2381781A1 (fr) Derives de la guanine et medicament contenant ces substances
ES453145A1 (es) Procedimiento para la preparacion de una sustancia de diag- nostico para la visualizacion renal.
IT1098328B (it) Sale sodico della mercapropropionilglicina,processo per la sua preparazione e suoi impieghi terapeutici
YU104986A (en) Process for obtaining penem derivatives
FR2392006A1 (fr) B-lactames monocycliques, leur procede de preparation et leur application en therapeutique
DE3160851D1 (en) Lidocaine derivative and therapeutic compositions which contain it as their active principle
ATE30582T1 (de) Ungesaettigte arylalkylammoniumsalze.
ES466677A1 (es) Un procedimiento de preparacion de derivados de cisteinol.
FR2411170A1 (fr) Procede de preparation de chlorure de pentachlorovinylacetyle
JPS55157514A (en) Anticancer drug solution comprising eosine yellowish as main constituent

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19981103